Production of chemokines in Kawasaki disease, Henoch-Schönlein purpura and acute febrile illness

Journal of Korean Medical Science

Volumn 19, Issue 6, 2004, Pages 800-804

  Chung, Hyo Seok ^a   Kim, Hyo Young ^a   Kim, Hee Sun ^a   Lee, Hee Jung ^a   Yuh, Ji Hyun ^a   Lee, Eun Sil ^a   Choi, Kwang Hae ^a   Lee, Young Hwan ^a,b  

^a Yeungnam University College of Medicine   (South Korea)

^b Young Nam University Hospital   (South Korea)

Author keywords

Acute Febrile Illness; Chemokines; Chemokines, CC; Chemokines, CXC; Exanthem Subitum; Gastroenteritis; Kawasaki Disease; Measles; Mucocutaneous Lymph Node Syndrome; Mumps; Pneumonia; Purpura, Sch nlein Henoch; Tonsillitis

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1;

ACUTE DISEASE; ANAPHYLACTOID PURPURA; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; FEVER; HUMAN; INFANT; MALE; MONOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL; ONCOGENE; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL;

EID: 12144251195     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2004.19.6.800     Document Type: Article

References (34)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi (Jpn J Allerg) 1967; 16: 178-222.
2. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrcs 1978; 61: 100-7.
3. Hirose S, Hamashima Y. Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome: A skin biopsy study of 27 patients. Eur J Pediatr 1978; 129: 17-27.
4. Leung DY. Immunologic aspects of Kawasaki syndrome. J Rheumatol Suppl 1990; 24: 15-8.
5. Cohen TJ, Kallenberg CG. Vasculitis, In Klinische Immunologie, edited by The TH, De Kallenberg CGM, Leij L, Houten/Antwerpen, Bohn Stafleu Van Loghum 1991; 216-33.
6. Schall TJ. The chemokines. In: The chemokine Handbook, 2nd ed. New york: Academic Press 1994; 419-60.
7. Ueno Y, Takano N, Kanegane H, Yokoi T, Yachie A, Miyawaki T, Taniguchi N. The acute phase nature of interleukin-6: studies in Kawasaki disease and other febrile illnesses. Clin Exp Immunol 1989; 76: 337-42.
8. Kim HS, Kim WD, Lee YH. Production and expression of Gro-α and RANTES by peripheral blood mononuclear cells isolated from patients with kawasaki disease and measles. J Korean Med Sci 2003; 18: 381-6.
9. Richmond A, Shattuck RL. Melanoma growth stimulatory activity: physiology, biology, structure/function, and role in disease. In: Horuk R, ed. Chemoattractant Ligands and their Receptors, Boca Raton, CRC Press, 1966; 87-124.
10. Mahanty S, Bausch DG, Thomas RL, Goba A, Bah A, Peters CJ, Rollin PE. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J Infect Dis 2001; 183: 1713-21.
11. Frangogiannis NG, Mendoza LH, Smith CW, Michael LH, Entman ML. Induction of the synthesis of the C-X-C chemokine interferon-γ-inducible protein-10 in experimental canine endotoxemia. Cell Tissue Res 2000; 302: 365-76.
12. Asano T, Ogawa S. Expression of monocyte chemoattractant protein-1 in Kawasaki Disease: The Anti-inflammatory effect of gamma globulin therapy. Scand J Immunol 2000; 51: 98-103.
13. Johnston B, Burns AR, Suematsu M, Issekutz TB, Woodman RC, Kubes P. Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. J Clin Invest 1999; 103: 1269-76.
14. Jibiki T, Terai M, Shima M, Ogawa A, Hamada H, Kanazawa M, Yamamoto S, Oana S, Kohno Y. Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Jananese patients with Kawasaki disease. Arthritis Rheum 2001; 44: 2211-12.
15. Tsuruta J, Sugisaki K, Dannenberg AM Jr, Yoshimura T, Abe Y, Mounts P. The cytokines NAP-1(IL-8), MCP-1, IL-1β and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation 1996; 20: 293-318.
16. Tettelbach W, Nanney L, Ellis D, King L, Richmond A. Localization of MGSA/GRO protein in cutaneous lesions. J Cutan Pathol 1993; 20: 259-66.
17. Koch AE, Kunkel SL, Shah MR, Hosaka S, Halloran MM, Haines GK, Burdick MD, Pope RM, Strieter RM. Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 1995; 155: 3660-6.
18. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992; 103: 1587-695.
19. Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, Kunkel SL. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol 1995; 57: 752-62.
20. Tanaka F, Dannenberg AM Jr, Higuchi K, Nakamura M, Pula PJ, Hugli TE, Discipio RG, Kreutzer DL. Chemotactic factors released in culture by intact developing and healing skin lesions produced in rabbits by the irritant sulfur mustard. Inflammation 1997; 21: 251-67.
21. Tsuruta J, Sugisaki K, Dannenberg AM Jr, Yoshimura T, Abe Y, Mounts P. The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation 1996; 20: 293-318.
22. Asano T, Ogawa S. Expression of IL-8 in Kawasaki disease. Clin Exp Immunol 2000; 122: 514-9.
23. Wong M, Silverman ED, Fish EN. Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1β expression in Kawasaki disease. J Rheumatol 1997; 24: 1179-85.
24. Suzuki H, Noda E, Miyawaki M, Takeuchi T, Uemura S, Koike M. Serum levels of neutrophil activation cytokines in Kawasaki disease. Pediatr Int 2001; 43: 115-9.
25. Han JW, Lee KY, Lee KS. Immunologic alterations of peripheral mononuclear cells by intravenous immunoglobulin in the acute stage of Kawasaki disease. J Korean Pediatr Soc 1998; 41: 813-24.
26. Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children (Henoch-Schönlein purpura syndrome). Am J Dis Child 1960; 99: 147-68.
27. Muslu A, Islek I, Gok F, Aliyazicioglu Y, Dagdemir A, Dundaroz R, Kucukoduk S, Sakarcan A. Endothelin levels in Henoch-Schönlein purpura. Pediatr Nephrol 2002; 17: 920-5.
28. Besas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A, Elnahas AM. The role of cytokines in Henoch-Schönlein purpura. Scand J Rheumatol 1997; 26: 456-60.
29. Wu TH, Wu SC, Huang TP, Yu CL, Tsai CY. Increased excretion of tumor necrosis factor alpha and interleukin 1β in urine from patients with IgA nephropathy and schonlein-Henöch purpura. Nephron 1996; 74: 79-88.
30. Besbas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A, Elnahas AM. The role of cytokines in Henoch Schönlein purpura. Scand J Rheumatol 1997; 26: 456-60.
31. Redhead K, Watkins J, Barnard A, Mills KH. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun 1993; 61: 3190-8.
32. Bucklin SE, Silverstein R, Morrison DC. An Interleukin-6-Induced acute-phase response does not confer protection against lipopolysaccharide lethality. Infect Immun 1993; 61: 3184-9.
33. Cha HS, Kim HS, Lee YS, Kim SK. Effect of C. albicans on IL-6 gene expression of human peripheral blood lymphocytes. Korean J Immunol 1997; 19: 263-75.
34. Valbuena G, Bradford W, Walker DH. Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group. Am J Pathol 2003; 163: 1357-69.